2023年1月6日

CareDX公司分子诊断涉及到一个大数组的应用技术,从分子生物学进行各种测试生物标记在基因组和蛋白质组分析。分子诊断是用来保持密切跟踪的传染病包括COVID-19,和艾滋病,其监控、风险,以及其他用途。的适用性等诊断实践是由于需求的上升趋势个性化和个性化药物治疗。推动市场增长的主要因素包括传染病和癌症的患病率的增加在全球各地。有成本效益的和准确的诊断需求的解决方案是另一个因素推动的增长市场。然而,严格的法律法规相关的分子诊断是主要因素抑制的增长市场。缺乏足够的基础设施在新兴国家的一个主要障碍在新兴市场的增长区域。政府的扩展支持的资金和科技进步的发展更精确的和具有成本效益的诊断设备将推动未来的市场。节段性展望全球分子诊断市场分割是基于技术,产品,和应用程序。基于技术、市场划分为PCR,多分,DNA微阵列,NSG、等温核酸扩增,和其他技术。 Based on the product, the market is segmented into testing equipment, diagnostic reagents & kits, and services & software. Apart from this, by applications, the market is segmented into infectious diseases, cancer, CVD, genetic testing, neurological disease, and other. Infectious Diseases are Dominating the Global Molecular Diagnostics Market The diagnostics of infectious diseases have taken a huge share in the molecular diagnostics market as these diseases tend to spread rapidly creating demand for their diagnosis. The spread COVID-19 in December 2019 is one of the best examples of infectious diseases. RT-PCR is guided to be the best testing method for its diagnosis. The diagnosis of other diseases are sidelined as per The Hindu news reports and the main focus of all the governments and market player across the globe is on the research and treatment of COVID-19. Cancer is at second in the molecular diagnostics market. According to an estimation of the American Cancer Society, four new cases have been recorded every minute in the US with one death. The weakening of the immune system as an impact of increasing pollution is resulting in the severity of these diseases. Genetic testing and research are emerging segments in this market. To get rid of genetic diseases this segment can play a major role in the future. Additionally, the extinguished species of plants and animals can also be revived through this technique. Revive&Restore organization is using it to bring Wooly Mammoth back into existence in Europe which was extinguished in the ice age. Regional Outlooks The global molecular diagnostics market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others, and the Rest of the World (the Middle East and Africa, and Latin America). The emerging countries such as India and China in the Asia-Pacific region are expected to grow significantly during the forecast attributed to the rapid development of the healthcare industry in such regions. North America is Leading the Global Molecular Diagnostics Market North America holds the major share in the molecular diagnostics market owing to the presence of a large number of companies both in the development and research of molecular diagnostic fields. The region also has the highest statistics related to cancer incidence. The European region follows North America in market share owing to the availability of well-established healthcare facilities and the increasing demand for personalized treatment. The Europe dominates in the testing kits segment of the market. The Report Covers Annualized market revenues ($ million) for each market segment. Country-wise analysis of major geographical regions. Key companies operating in the global molecular diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report. Analysis of business strategies by identifying the key market segments positioned for strong growth in the future. Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market. Key Topics Covered: